DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Latin America, Africa and Middle East Version" report has been added to Research and Markets' offering.
A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Latin America, Africa and Middle East Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
- Changing demographics
- Emerging economies and global prosperity
- Biotechnology advances in genetics
- Pathogen evolution
- Climate change
Key Topics Covered:
1. Introduction and Market Definition
2. Overview of a Dynamic Market
3. Trends Driving a Changing Market
4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
5. Country Markets - Latin America, Africa & The Middle East 2014 to 2022
6. The Future of the Clinical Laboratory
For more information about this report visit https://www.researchandmarkets.com/research/rf6w3g/in_vitro